Live Breaking News & Updates on Anticancer Therapies

Stay updated with breaking news from Anticancer therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MK-1084 Alone and Plus Pembrolizumab Shows Early Safety, Activity in KRAS G12C+ Solid Tumors

MK-1084 Alone and Plus Pembrolizumab Shows Early Safety, Activity in KRAS G12C+ Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Carlos Rojas , Bradford Hill , Investigacion Clinica , Anticancer Therapies Congress , Anticancer Therapies , Centro De Investigacion Clinica ,

TNO155 Plus Spartalizumab or Ribociclib Elicits Disease Control, Is Safe in Advanced Solid Tumors

TNO155 plus spartalizumab or ribociclib was well tolerated and demonstrated disease control in patients with advanced solid tumors. ....

Israel General , Comunidad Autonoma De Cataluna , Omar Saavedra , Anticancer Therapies Congress , Hebron Institute Of Oncology , Early Drug Development Unit , Anticancer Therapies , Hebron Institute , Smo Targeted Anticancer Therapies Congress , Solid Tumors ,

Targeted Delivery of IL-12 Shows Preliminary Antitumor Activity in Advanced Solid Tumors

A high proportion of patients with metastatic solid tumors experienced stable disease following treatment with the immunocytokine in the DODEKA trial. ....

Giuseppe Curigliano , University Of Milano , Anticancer Therapies Congress , Anticancer Therapies , Medical Oncology , Clinical Division , Early Drug Development , European Institute , Istituto Europeo , Exact Sciences , Smo Targeted Anticancer Therapies Congress , Solid Tumors ,

LoRusso named the Amy and Joseph Perella Professor of Medicine

Patricia LoRusso is an internationally recognized expert in drug development and early-phase clinical investigation of novel cancer therapies. ....

United States , Patricia Lorusso , Clinical Cancer Research , Burchenal Award For Clinical Cancer Research , American Association For Cancer Research , Clinical Trials Task , Eisenberg Center , National Organization Of Italian American Women , National Cancer Institute , World Affairs Council Of Connecticut , American Society Of Clinical Oncology , Michigan State University Distinguished Alumni Award , Hospital Cancer Center One , Precision Combination Therapy Task , Cancer Therapy Evaluation Program , Global Affairs Committee , Marygrove College , Extraordinary Achievements In Cancer Research Award Committee , Michaelec Christian Oncology Development Lectureship , Michigan State University , Yale School Of Medicine , Phasei Clinical Trials Program , Investigational Drug Steering Committee , Developmental Therapeutics At Yale Cancer Center , Joseph Perella Professor , Yale School ,

Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates

Phase 1b/2 trial of AsiDNA™ in combination with olaparib in the United States in recurrent ovarian, breast and metastatic castration-resistant prostate cancer continues to enroll. | April 24, 2023 ....

United States , San Antonio , France General , Shefali Agarwal , Institut Curie , Julien Miara , Gustave Roussy , Judith Greciet , Onxeo Sa Euronext , Danielle Guyot Caparros , Marie Dutreix Institut Curie , Drug Administration , Gilles Favre Toulouse Cancer Research Center , Company Group , Anticancer Therapies Congress , European Union , American Association For Cancer Research , Regulatory News , Euronext Growth Paris , Investigational New Drug , Gustave Roussy Cancer Campus , Anticancer Therapies , American Association , Cancer Research , Annual Meeting , Gilles Favre ,